Companies / Financials
GL
Globe Life
Life & Health Insurance
Life & Health InsuranceAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health73
Growth39
Profitability81
Cash generationn/a
Balance sheetn/a
Dilution control100
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)5.5%Revenue growth (FY)3.7%Revenue CAGR (3y)4.7%Gross margin—Operating margin—Net margin19.4%Free cash flow margin20.9%R&D / revenue—Stock comp / revenue0.9%Net debt / operating cash flow1.78xCurrent ratio—Diluted share count change-8.0%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $5.1B | $5.2B | $5.4B | $5.8B | $6.0B |
| Gross profit | $1.2B | $1.2B | $1.3B | — | — |
| Operating income | $1.2B | $1.2B | $1.3B | — | — |
| Net income | $1.0B | $894M | $971M | $1.1B | $1.2B |
| Operating cash flow | $1.4B | $1.4B | $1.5B | $1.4B | $1.4B |
| Capital expenditure | $38M | $28M | $50M | $71M | $142M |
| Free cash flow | $1.4B | $1.4B | $1.4B | $1.3B | $1.3B |
| Stock-based comp | $30M | $36M | $31M | $40M | $53M |
| Buybacks | $541M | $455M | $511M | $1.0B | $881M |
| Dividends | $80M | $81M | $84M | $85M | $86M |
| Cash | $92M | $93M | $103M | $165M | $145M |
| Total debt | $2.3B | $2.4B | $2.1B | $2.7B | $2.6B |
| Equity | $2.0B | $3.9B | $4.5B | $5.3B | $6.0B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.